PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-16.27%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-18.09%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-37.33%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-37.33%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-7.16%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
19.09%
Positive EPS growth while CVE is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
19.36%
Positive diluted EPS growth while CVE is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-7.63%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-8.96%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
54.70%
Maintaining or increasing dividends while CVE cut them. John Neff might see a strong edge in shareholder returns.
-4.41%
Negative OCF growth while CVE is at 80.53%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-68.29%
Negative FCF growth while CVE is at 1306.98%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-4.98%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-4.98%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-4.98%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
91.92%
Positive long-term OCF/share growth while CVE is negative. John Neff would see a structural advantage in sustained cash generation.
91.92%
5Y OCF/share CAGR is similar to CVE's 100.00%. Walter Schloss might see parallel cost profiles or expansions producing comparable cash flow.
91.92%
Positive 3Y OCF/share CAGR while CVE is negative. John Neff might see a big short-term edge in operational efficiency.
84.33%
Positive 10Y CAGR while CVE is negative. John Neff might see a substantial advantage in bottom-line trajectory.
84.33%
5Y net income/share CAGR at 75-90% of CVE's 100.00%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
84.33%
Positive short-term CAGR while CVE is negative. John Neff would see a clear advantage in near-term profit trajectory.
-5.69%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
-5.69%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-5.69%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
-9.76%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-9.76%
Negative 5Y dividend/share CAGR while CVE stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-9.76%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
-17.71%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
52.18%
We show growth while CVE is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
9.68%
Positive asset growth while CVE is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
20.82%
Positive BV/share change while CVE is negative. John Neff sees a clear edge over a competitor losing equity.
14.53%
We have some new debt while CVE reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
4.40%
We expand SG&A while CVE cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.